TL;DR
This paper tackles the challenge of creating uniform, consistent spheroids for preclinical cancer research by developing a surface-optimized polydimethylsiloxane (PDMS) microfluidic platform. By treating the PDMS with a specific concentration of bovine serum albumin (BSA), they effectively reduce non-specific cell adhesion, promoting cell-cell interactions and leading to highly uniform spheroid formation across multiple cancer cell lines and co-culture models.
What Problem Does This Paper Address?
Preclinical cancer research heavily relies on in vitro models to test drug efficacy and understand disease mechanisms. While 2D cell cultures offer simplicity, they fail to recapitulate the complex 3D tumor microenvironment. Spheroids, or 3D cell aggregates, offer a more physiologically relevant model, mimicking key aspects of in vivo tumors. However, achieving uniform spheroids in terms of size, shape, and density has been a significant hurdle. Traditional methods like hanging drops or spinner flasks often result in inconsistent aggregates. Microfluidic devices offer better control, but the inherent properties of common materials like PDMS, particularly their tendency to promote cell adhesion, can interfere with the self-assembly process required for spheroid formation. This paper addresses the need for a reliable and reproducible method to generate uniform spheroids on-chip by optimizing the surface properties of PDMS microfluidic devices.
Methods
The researchers developed a microfluidic biochip platform using polydimethylsiloxane (PDMS). The key innovation lies in the surface treatment of the PDMS channels. They explored two concentrations of bovine serum albumin (BSA): 3% and 10%. The rationale behind BSA treatment is to create a more hydrophilic surface that repels cell adhesion, thereby favoring cell-cell interactions over cell-substrate interactions. This promotes the self-assembly of cells into spheroids.
The microfluidic devices themselves were fabricated using soft lithography with 3D-printed molds. The design was adapted from previous work, with a crucial modification: the cell-trapping chambers were changed from a cube shape to a cylindrical shape. This geometric change was intended to prevent cells from sticking to the corners of the microwells, further promoting uniform aggregation.
The study involved culturing six different human cancer cell lines (MDA-MB231, A549, H1299, C4-2B, U251) and a co-culture model (A549 and IRM-90 fibroblasts) on these surface-treated chips. Spheroid formation and proliferation were monitored over seven days using epifluorescence microscopy. Image J software was used to quantify spheroid size, brightness level ratio (as an indicator of proliferation), and circularity. Statistical analysis was performed using one-way ANOVA and Tukey tests.
Datasets
Not discussed in the paper. The study utilizes established human cancer cell lines and fibroblast cell lines for their experiments.
Key Insights and Ideas
- BSA concentration is critical: The study highlights that the concentration of BSA is paramount. While 3% BSA showed some cell-repellent properties, 10% BSA was found to be optimal for effectively suppressing cell adhesion and promoting spheroid formation.
- Surface modification is key to spheroid uniformity: The research strongly emphasizes that controlling the surface properties of the microfluidic device is as important as the device design itself for achieving uniform spheroids.
- Cylindrical microwells improve aggregation: Modifying the microwell geometry from cubic to cylindrical was shown to enhance cell aggregation and lead to more centered spheroid formation.
- Cell-type specific responses: While the 10% BSA treatment generally promoted spheroid formation, the study observed variations in proliferation rates and the time it took for certain cell lines (like C4-2B) to form stable spheroids, indicating that cell-specific characteristics still play a role.
- Co-culture models benefit from surface optimization: The optimized surface treatment also proved effective for generating spheroids in co-culture models, which are more representative of the tumor microenvironment.
Key Results
- Uniform Spheroid Formation: Biochips treated with 10% BSA consistently produced uniform and homogenous spheroids from six different human cell lines and a co-culture model.
- Reduced Cell Adhesion: The 10% BSA treatment significantly reduced cell adhesion to the PDMS surface compared to bare PDMS or PDMS treated with 3% BSA.
- Improved Spheroid Quality: The 10% BSA treated surfaces led to better spheroid quality, characterized by more compact and spherical aggregates.
- Spheroid Growth Monitored: The study successfully monitored spheroid growth and proliferation over seven days, observing cell-type-dependent growth patterns.
- Co-culture Model Success: The surface-optimized platform facilitated the formation of multicellular tumor spheroids (MCTSs) from co-cultures of tumor and stromal cells, with no significant difference observed in spheroid characteristics when varying the ratio of tumor to stromal cells.
Limitations and Future Work
- Cell-type variability: While the 10% BSA treatment was effective across multiple cell lines, the study noted that spheroid formation timelines and proliferation rates varied depending on the cell line. Some cell lines, like C4-2B, took longer to form stable spheroids.
- Future Work: The authors suggest future work could involve capturing patient-derived circulating tumor cells from liquid biopsies and assessing the impact of spheroid formation from patient-derived solid tumors and stromal cells. They also envision this platform being used for assessing the efficacy of various therapeutic strategies in vitro and for developing more sophisticated organ-on-a-chip applications. Further research into the fundamental interactions between cells and surfaces is also proposed to enable better control of cell function.
Summary updated